How low is the risk of influenza A(H5N1) infection?

Affiliations

Editorial

David M Morens et al. J Infect Dis. 2015.

. 2015 May 1;211(9):1364-6.

doi: 10.1093/infdis/jiu530. Epub 2014 Oct 29.

¹ National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland.

No abstract available

Keywords: H5N1; H7N9; influenza; pandemic; seroepidemiology; serology.

Comment on

Avian influenza A(H5N1) and A(H9N2) seroprevalence and risk factors for infection among Egyptians: a prospective, controlled seroepidemiological study.
Gomaa MR, Kayed AS, Elabd MA, Zeid DA, Zaki SA, El Rifay AS, Sherif LS, McKenzie PP, Webster RG, Webby RJ, Ali MA, Kayali G. Gomaa MR, et al. J Infect Dis. 2015 May 1;211(9):1399-407. doi: 10.1093/infdis/jiu529. Epub 2014 Oct 29. J Infect Dis. 2015. PMID: 25355942 Free PMC article.

1. Russell CA, Fonville JM, Brown AE, et al. The potential for respiratory droplet-transmissible A/H5N1 influenza virus to evolve in a mammalian host. Science 2012; 336:1541–7. - PMC - PubMed
1. World Health Organization. Cumulative number of confirmed human cases of avian influenza A(H5N1) reported to WHO. http://www.who.int/influenza/human_animal_interface/EN_GIP_20140124Cumul... Accessed 9 October 2014.
1. Sample I. Scientists condemn ‘crazy, dangerous’ creation of deadly airborne flu virus. The Guardian. 11 June2014. http://www.theguardian.com/science/2014/jun/11/crazy-dangerous-creation-.... Accessed 9 October 2014.
1. The Cambridge Working Group. Cambridge Working Group Consensus Statement on the Creation of Potential Pandemic Pathogens (PPPs). http://www.cambridgeworkinggroup.org. Accessed 9 October 2014.
1. Patterson AP, Tabak LA, Fauci AS, Collins FS, Howard S. Research funding. A framework for decisions about research with HPAI H5N1 viruses. Science 2013; 339:1036–7. - PMC - PubMed